{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:53:51Z","timestamp":1787003631642,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T00:00:00Z","timestamp":1681171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T00:00:00Z","timestamp":1681171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Private donations"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Increasing numbers of individuals have access to cannabinoid-based products containing various amounts of delta-9-tetrahydrocannabinol (THC), cannabidiol (CBD), and other cannabinoids. Exposure to specific cannabinoids likely influences outcomes; however, current methods for quantifying cannabis exposure do not account for the cannabinoid concentrations of the products used. We developed CannaCount, an examiner-driven metric that quantifies estimated maximum possible cannabinoid exposure by accounting for variables related to cannabinoid concentration, duration, frequency, and quantity of use. To demonstrate feasibility and applicability, CannaCount was used to quantify estimated maximum THC and CBD exposure in 60 medical cannabis patients enrolled in a two-year, longitudinal, observational study. Medical cannabis patients reported using a variety of product types and routes of administration. Calculating estimated exposure to THC and CBD was possible for the majority of study visits, and the ability to generate estimated cannabinoid exposure improved over time, likely a function of improved product labeling, laboratory testing, and more informed consumers. CannaCount is the first metric to provide estimated maximum possible exposure to individual cannabinoids based on actual cannabinoid concentrations. This metric will ultimately facilitate cross-study comparisons and can provide researchers and clinicians with detailed information regarding exposure to specific cannabinoids, which will likely have significant clinical impact.<\/jats:p>","DOI":"10.1038\/s41598-023-32671-9","type":"journal-article","created":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T05:02:51Z","timestamp":1681189371000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["CannaCount: an improved metric for quantifying estimates of maximum possible cannabinoid exposure"],"prefix":"10.1038","volume":"13","author":[{"given":"Ashley M.","family":"Lambros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly A.","family":"Sagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Kathryn","family":"Dahlgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz","family":"Kosereisoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine","family":"El-Abboud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary T.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Staci A.","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,11]]},"reference":[{"key":"32671_CR1","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1037\/a0030992","volume":"28","author":"SM Robinson","year":"2014","unstructured":"Robinson, S. M., Sobell, L. C., Sobell, M. B. & Leo, G. I. Reliability of the timeline followback for cocaine, cannabis, and cigarette use. Psychol. Addict. Behav. 28, 154\u2013162. https:\/\/doi.org\/10.1037\/a0030992 (2014).","journal-title":"Psychol. Addict. Behav."},{"key":"32671_CR2","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/j.1360-0443.1988.tb00485.x","volume":"83","author":"LC Sobell","year":"1988","unstructured":"Sobell, L. C., Sobell, M. B., Leo, G. I. & Cancilla, A. Reliability of a timeline method: Assessing normal drinkers\u2019 reports of recent drinking and a comparative evaluation across several populations. Br. J. Addict. 83, 393\u2013402 (1988).","journal-title":"Br. J. Addict."},{"key":"32671_CR3","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3109\/16066359.2011.569101","volume":"20","author":"C Zeisser","year":"2012","unstructured":"Zeisser, C. et al. A \u2018standard joint\u2019? The role of quantity in predicting cannabis-related problems. Addict. Res. Theory 20, 82\u201392. https:\/\/doi.org\/10.3109\/16066359.2011.569101 (2012).","journal-title":"Addict. Res. Theory"},{"key":"32671_CR4","doi-asserted-by":"publisher","first-page":"298","DOI":"10.15288\/jsad.2016.77.298","volume":"77","author":"MK Dahlgren","year":"2016","unstructured":"Dahlgren, M. K., Sagar, K. A., Racine, M. T., Dreman, M. W. & Gruber, S. A. Marijuana use predicts cognitive performance on tasks of executive function. J. Stud. Alcohol Drugs 77, 298\u2013208 (2016).","journal-title":"J. Stud. Alcohol Drugs"},{"key":"32671_CR5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.neulet.2012.01.039","volume":"511","author":"SA Gruber","year":"2012","unstructured":"Gruber, S. A., Dahlgren, M. K., Sagar, K. A., Gonenc, A. & Killgore, W. D. Age of onset of marijuana use impacts inhibitory processing. Neurosci. Lett. 511, 89\u201394. https:\/\/doi.org\/10.1016\/j.neulet.2012.01.039 (2012).","journal-title":"Neurosci. Lett."},{"key":"32671_CR6","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1007\/s00213-013-3326-z","volume":"231","author":"SA Gruber","year":"2014","unstructured":"Gruber, S. A., Dahlgren, M. K., Sagar, K. A., Gonenc, A. & Lukas, S. E. Worth the wait: Effects of age of onset of marijuana use on white matter and impulsivity. Psychopharmacology 231, 1455\u20131465. https:\/\/doi.org\/10.1007\/s00213-013-3326-z (2014).","journal-title":"Psychopharmacology"},{"key":"32671_CR7","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1037\/a0026269","volume":"26","author":"SA Gruber","year":"2012","unstructured":"Gruber, S. A., Sagar, K. A., Dahlgren, M. K., Racine, M. & Lukas, S. E. Age of onset of marijuana use and executive function. Psychol. Addict. Behav. 26, 496\u2013506. https:\/\/doi.org\/10.1037\/a0026269 (2012).","journal-title":"Psychol. Addict. Behav."},{"key":"32671_CR8","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.dcn.2015.03.003","volume":"16","author":"KA Sagar","year":"2015","unstructured":"Sagar, K. A. et al. The impact of initiation: Early onset marijuana smokers demonstrate altered Stroop performance and brain activation. Dev. Cogn. Neurosci. 16, 84\u201392. https:\/\/doi.org\/10.1016\/j.dcn.2015.03.003 (2015).","journal-title":"Dev. Cogn. Neurosci."},{"key":"32671_CR9","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1080\/13803395.2015.1020770","volume":"37","author":"NA Crane","year":"2015","unstructured":"Crane, N. A., Schuster, R. M., Mermelstein, R. J. & Gonzalez, R. Neuropsychological sex differences associated with age of initiated use among young adult cannabis users. J. Clin. Exp. Neuropsychol. 37, 389\u2013401. https:\/\/doi.org\/10.1080\/13803395.2015.1020770 (2015).","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"32671_CR10","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1007\/s11469-021-00708-7","volume":"1\u20137","author":"SJ Bartel","year":"2021","unstructured":"Bartel, S. J., Sherry, S. B. & Stewart, S. H. Pandemic-related changes in alcohol and cannabis use: Comparing retrospective reports and prospective data. Int. J. Ment. Health Addict. 1\u20137, 2021. https:\/\/doi.org\/10.1007\/s11469-021-00708-7 (2021).","journal-title":"Int. J. Ment. Health Addict."},{"key":"32671_CR11","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1111\/j.1369-1600.2012.00498.x","volume":"18","author":"J Cousijn","year":"2013","unstructured":"Cousijn, J. et al. Individual differences in decision making and reward processing predict changes in cannabis use: A prospective functional magnetic resonance imaging study. Addict. Biol. 18, 1013\u20131023. https:\/\/doi.org\/10.1111\/j.1369-1600.2012.00498.x (2013).","journal-title":"Addict. Biol."},{"key":"32671_CR12","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/adb.12111","volume":"19","author":"J Cousijn","year":"2014","unstructured":"Cousijn, J. et al. Relationship between working-memory network function and substance use: A 3-year longitudinal fMRI study in heavy cannabis users and controls. Addict. Biol. 19, 282\u2013293. https:\/\/doi.org\/10.1111\/adb.12111 (2014).","journal-title":"Addict. Biol."},{"key":"32671_CR13","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.addbeh.2017.12.009","volume":"79","author":"ME Lovell","year":"2018","unstructured":"Lovell, M. E. et al. Cognitive, physical, and mental health outcomes between long-term cannabis and tobacco users. Addict. Behav. 79, 178\u2013188. https:\/\/doi.org\/10.1016\/j.addbeh.2017.12.009 (2018).","journal-title":"Addict. Behav."},{"key":"32671_CR14","doi-asserted-by":"publisher","first-page":"461029","DOI":"10.1155\/2013\/461029","volume":"2013","author":"JT Sneider","year":"2013","unstructured":"Sneider, J. T., Gruber, S. A., Rogowska, J., Silveri, M. M. & Yurgelun-Todd, D. A. A preliminary study of functional brain activation among marijuana users during performance of a virtual water maze task. J. Addict. 2013, 461029. https:\/\/doi.org\/10.1155\/2013\/461029 (2013).","journal-title":"J. Addict."},{"key":"32671_CR15","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.drugalcdep.2010.08.008","volume":"113","author":"JJ Mariani","year":"2011","unstructured":"Mariani, J. J., Brooks, D., Haney, M. & Levin, F. R. Quantification and comparison of marijuana smoking practices: Blunts, joints, and pipes. Drug Alcohol Depend. 113, 249\u2013251. https:\/\/doi.org\/10.1016\/j.drugalcdep.2010.08.008 (2011).","journal-title":"Drug Alcohol Depend."},{"key":"32671_CR16","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.drugalcdep.2011.09.007","volume":"121","author":"MM Norberg","year":"2012","unstructured":"Norberg, M. M., Mackenzie, J. & Copeland, J. Quantifying cannabis use with the timeline followback approach: A psychometric evaluation. Drug Alcohol Depend. 121, 247\u2013252. https:\/\/doi.org\/10.1016\/j.drugalcdep.2011.09.007 (2012).","journal-title":"Drug Alcohol Depend."},{"key":"32671_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2017.09.035","volume":"182","author":"RL Tomko","year":"2018","unstructured":"Tomko, R. L. et al. Incremental validity of estimated cannabis grams as a predictor of problems and cannabinoid biomarkers: Evidence from a clinical trial. Drug Alcohol Depend. 182, 1\u20137. https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.09.035 (2018).","journal-title":"Drug Alcohol Depend."},{"key":"32671_CR18","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1080\/10550490903077705","volume":"18","author":"M Bonn-Miller","year":"2009","unstructured":"Bonn-Miller, M. & Zvolensky, M. An evaluation of the nature of marijuana use and its motives among young adult active users. Am. J. Addict. 18, 409\u2013416. https:\/\/doi.org\/10.1080\/10550490903077705 (2009).","journal-title":"Am. J. Addict."},{"key":"32671_CR19","doi-asserted-by":"publisher","first-page":"e0178194","DOI":"10.1371\/journal.pone.0178194","volume":"12","author":"C Cuttler","year":"2017","unstructured":"Cuttler, C. & Spradlin, A. Measuring cannabis consumption: Psychometric properties of the daily sessions, frequency, age of onset, and quantity of cannabis use inventory (DFAQ-CU). PLoS ONE 12, e0178194. https:\/\/doi.org\/10.1371\/journal.pone.0178194 (2017).","journal-title":"PLoS ONE"},{"key":"32671_CR20","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1111\/add.14842","volume":"115","author":"TP Freeman","year":"2020","unstructured":"Freeman, T. P. & Lorenzetti, V. \u201cStandard THC units\u201d: A proposal to standardize dose across all cannabis products and methods of administration. Addiction 115, 1207\u20131216. https:\/\/doi.org\/10.1111\/add.14842 (2020).","journal-title":"Addiction"},{"key":"32671_CR21","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1089\/can.2016.0025","volume":"1","author":"RR Wetherill","year":"2016","unstructured":"Wetherill, R. R., Hager, N., Guthier, E. & Franklin, T. R. Gram years: A method to standardize and quantify lifetime cannabis consumption. Cannabis Cannabinoid Res. 1, 216\u2013217. https:\/\/doi.org\/10.1089\/can.2016.0025 (2016).","journal-title":"Cannabis Cannabinoid Res."},{"key":"32671_CR22","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.drugalcdep.2017.03.010","volume":"176","author":"C Casajuana-Kogel","year":"2017","unstructured":"Casajuana-Kogel, C. et al. The standard joint unit. Drug Alcohol Depend. 176, 109\u2013116. https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.03.010 (2017).","journal-title":"Drug Alcohol Depend."},{"key":"32671_CR23","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/s2215-0366(18)30088-9","volume":"5","author":"C Hindocha","year":"2018","unstructured":"Hindocha, C., Norberg, M. M. & Tomko, R. L. Solving the problem of cannabis quantification. The Lancet Psychiatry 5, 22. https:\/\/doi.org\/10.1016\/s2215-0366(18)30088-9 (2018).","journal-title":"The Lancet Psychiatry"},{"key":"32671_CR24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00406-019-00983-5","volume":"269","author":"S Chandra","year":"2019","unstructured":"Chandra, S. et al. New trends in cannabis potency in USA and Europe during the last decade (2008\u20132017). Eur. Arch. Psychiatry Clin. Neurosci. 269, 5\u201315. https:\/\/doi.org\/10.1007\/s00406-019-00983-5 (2019).","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"32671_CR25","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.biopsych.2016.01.004","volume":"79","author":"MA ElSohly","year":"2016","unstructured":"ElSohly, M. A. et al. Changes in cannabis potency over the last 2 decades (1995\u20132014): Analysis of current data in the United States. Biol. Psychiatry 79, 613\u2013619. https:\/\/doi.org\/10.1016\/j.biopsych.2016.01.004 (2016).","journal-title":"Biol. Psychiatry"},{"key":"32671_CR26","doi-asserted-by":"publisher","first-page":"e70052","DOI":"10.1371\/journal.pone.0070052","volume":"8","author":"W Swift","year":"2013","unstructured":"Swift, W., Wong, A., Li, K. M., Arnold, J. C. & McGregor, I. S. Analysis of cannabis seizures in NSW, Australia: Cannabis potency and cannabinoid profile. PLoS ONE 8, e70052. https:\/\/doi.org\/10.1371\/journal.pone.0070052 (2013).","journal-title":"PLoS ONE"},{"key":"32671_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1542\/peds.2015-0454","volume":"136","author":"JM Stogner","year":"2015","unstructured":"Stogner, J. M. & Miller, B. L. Assessing the dangers of \u201cdabbing\u201d: Mere marijuana or harmful new trend?. Pediatrics 136, 1\u20133. https:\/\/doi.org\/10.1542\/peds.2015-0454 (2015).","journal-title":"Pediatrics"},{"key":"32671_CR28","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.drugalcdep.2018.05.022","volume":"190","author":"KA Sagar","year":"2018","unstructured":"Sagar, K. A., Lambros, A. M., Dahlgren, M. K., Smith, R. T. & Gruber, S. A. Made from concentrate? A national web survey assessing dab use in the United States. Drug Alcohol Depend. 190, 133\u2013142. https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.05.022 (2018).","journal-title":"Drug Alcohol Depend."},{"key":"32671_CR29","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1001\/jama.2017.11909","volume":"318","author":"MO Bonn-Miller","year":"2017","unstructured":"Bonn-Miller, M. O. et al. Labeling accuracy of cannabidiol extracts sold online. JAMA 318, 1708\u20131709. https:\/\/doi.org\/10.1001\/jama.2017.11909 (2017).","journal-title":"JAMA"},{"key":"32671_CR30","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1001\/jama.2015.6613","volume":"313","author":"R Vandrey","year":"2015","unstructured":"Vandrey, R. et al. Cannabinoid dose and label accuracy in edible medical cannabis products. JAMA 313, 2491\u20132493. https:\/\/doi.org\/10.1001\/jama.2015.6613 (2015).","journal-title":"JAMA"},{"key":"32671_CR31","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1177\/1039856220965334","volume":"29","author":"K Oldfield","year":"2021","unstructured":"Oldfield, K. et al. A systematic review of the label accuracy of cannabinoid-based products in regulated markets: Is what\u2019s on the label what\u2019s in the product?. Australas. Psychiatry 29, 88\u201396 (2021).","journal-title":"Australas. Psychiatry"},{"key":"32671_CR32","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1089\/can.2017.0024","volume":"2","author":"C Hindocha","year":"2017","unstructured":"Hindocha, C., Freeman, T. P. & Curran, H. V. Anatomy of a joint: Comparing self-reported and actual dose of cannabis and tobacco in a joint, and how these are influenced by controlled acute administration. Cannabis Cannabinoid Res. 2, 217\u2013223. https:\/\/doi.org\/10.1089\/can.2017.0024 (2017).","journal-title":"Cannabis Cannabinoid Res."},{"key":"32671_CR33","doi-asserted-by":"publisher","first-page":"110113","DOI":"10.1016\/j.forsciint.2019.110113","volume":"307","author":"M Dei-Cas","year":"2020","unstructured":"Dei-Cas, M. et al. The Italian panorama of cannabis light preparation: Determination of cannabinoids by LC-UV. Forensic Sci. Int. 307, 110113. https:\/\/doi.org\/10.1016\/j.forsciint.2019.110113 (2020).","journal-title":"Forensic Sci. Int."},{"key":"32671_CR34","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1477-7517-5-20","volume":"5","author":"N Walden","year":"2008","unstructured":"Walden, N. & Earleywine, M. How high: Quantity as a predictor of cannabis-related problems. Harm. Reduct. J. 5, 20. https:\/\/doi.org\/10.1186\/1477-7517-5-20 (2008).","journal-title":"Harm. Reduct. J."},{"key":"32671_CR35","doi-asserted-by":"publisher","DOI":"10.1089\/can.2020.0079","author":"DJ Kruger","year":"2021","unstructured":"Kruger, D. J., Korach, N. J. & Kruger, J. S. Requirements for cannabis product labeling by US state. Cannabis Cannabin. Res. https:\/\/doi.org\/10.1089\/can.2020.0079 (2021).","journal-title":"Cannabis Cannabin. Res."},{"key":"32671_CR36","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1089\/can.2019.0101","volume":"5","author":"J Corroon","year":"2020","unstructured":"Corroon, J., MacKay, D. & Dolphin, W. Labeling of cannabidiol products: A public health perspective. Cannabis Cannabin. Res. 5, 274\u2013278. https:\/\/doi.org\/10.1089\/can.2019.0101 (2020).","journal-title":"Cannabis Cannabin. Res."},{"key":"32671_CR37","doi-asserted-by":"publisher","first-page":"107843","DOI":"10.1016\/j.drugalcdep.2020.107843","volume":"208","author":"C Leos-Toro","year":"2020","unstructured":"Leos-Toro, C., Fong, G. T., Meyer, S. B. & Hammond, D. Cannabis labelling and consumer understanding of THC levels and serving sizes. Drug Alcohol Depend. 208, 107843. https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.107843 (2020).","journal-title":"Drug Alcohol Depend."},{"key":"32671_CR38","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1037\/adb0000370","volume":"32","author":"MA Prince","year":"2018","unstructured":"Prince, M. A., Conner, B. T. & Pearson, M. R. Quantifying cannabis: A field study of marijuana quantity estimation. Psychol. Addict. Behav. 32, 426\u2013433. https:\/\/doi.org\/10.1037\/adb0000370 (2018).","journal-title":"Psychol. Addict. Behav."},{"key":"32671_CR39","doi-asserted-by":"publisher","DOI":"10.1177\/1477370820983560","author":"K Skliamis","year":"2020","unstructured":"Skliamis, K., Benschop, A. & Korf, D. J. Cannabis users and stigma: A comparison of users from European countries with different cannabis policies. Eur. J. Criminol. https:\/\/doi.org\/10.1177\/1477370820983560 (2020).","journal-title":"Eur. J. Criminol."},{"key":"32671_CR40","first-page":"149","volume":"7","author":"P Sharma","year":"2012","unstructured":"Sharma, P., Murthy, P. & Bharath, M. M. Chemistry, metabolism, and toxicology of cannabis: Clinical implications. Iran J. Psychiatry 7, 149\u2013156 (2012).","journal-title":"Iran J. Psychiatry"},{"key":"32671_CR41","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1002\/cbdv.200790152","volume":"4","author":"MA Huestis","year":"2007","unstructured":"Huestis, M. A. Human cannabinoid pharmacokinetics. Chem. Biodivers. 4, 1770\u20131804. https:\/\/doi.org\/10.1002\/cbdv.200790152 (2007).","journal-title":"Chem. Biodivers."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-32671-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-32671-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-32671-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T06:16:58Z","timestamp":1681193818000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-32671-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,11]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["32671"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-32671-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,11]]},"assertion":[{"value":"27 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing interests: S.A.G. reported grants from the National Institute on Drug Abuse, the Center for Medical Cannabis Research (CMCR), Foria\/Praxis Ventures, and Charlotte's Web for projects outside the submitted work. Over the last five years, S.A.G. has reported receiving fees from the Coalition for Cannabis Policy, Education, and Regulation (CPEAR), Beth Israel Deaconess, Fenway Health, Greenwich Biosciences Cannabis Education Working Group, National Academy of Neuropsychology, McMaster University, Harvard Health Publications, University of Florida, and the Massachusetts College of Pharmacy and Health Sciences, all related to presentations outside the submitted work. S.A.G. is also a scientific advisor for Ajna Biosciences. M.K.D. reported receiving the McLean Hospital Jonathan Edward Brooking Mental Health Research Fellowship outside the submitted work. K.A.S. reported receiving the McLean Hospital Eleanor and Miles Shore Fellowship and the Charles Robert Broderick III Phytocannabinoid Research Fellowship, and reported receiving fees from CPEAR outside the submitted work. All other authors have no competing interests to declare. No funding sources were involved in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5869"}}